F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
E

Failure to Monitor Psychotropic Medications for Effectiveness and Side Effects

Harris Health Center LlcEast Providence, Rhode Island Survey Completed on 01-30-2026

Summary

The deficiency involves the facility’s failure to ensure adequate monitoring for effectiveness and side effects of psychotropic medications for multiple residents. The facility’s own policy on Medication Administration Safety; Psychotropic Medications and New Medication Orders requires that nonpharmacological interventions be attempted before psychotropic medications are ordered, and that new medications be monitored for effectiveness and side effects, with systems in place for re-evaluation by the IDT and care plan interventions addressing monitoring. Despite this policy, record reviews for several residents on psychotropic medications did not contain evidence of such monitoring. One resident with schizoaffective disorder was prescribed lithium carbonate and olanzapine, with a care plan directing monitoring of medication effectiveness, side effects, mood, and behaviors, yet the clinical record lacked documentation of this monitoring. Another resident with dementia was prescribed memantine, Rexulti, Seroquel, and trazodone, and had a care plan focus identifying risk for adverse effects from daily psychotropic use with an intervention to monitor mood/behavior and report adverse effects or ineffectiveness, but the record similarly lacked evidence of monitoring for effectiveness and side effects. A third resident with Alzheimer’s disease was prescribed Seroquel, trazodone, mirtazapine, and olanzapine, with a care plan intervention to monitor for changes in mood/behavior and adverse effects, but again, no documentation of such monitoring was found in the record. Additional residents were affected in the same manner. One resident with major depressive disorder was prescribed buspirone and venlafaxine, with a care plan focus on risk for adverse effects from psychotropic medications and an intervention to monitor mood/behavior and report side effects or ineffectiveness, yet the record contained no evidence of monitoring. Another resident with bipolar disorder was prescribed clozapine, divalproex, mirtazapine, and sertraline, with a care plan intervention to monitor for adverse effects and report changes, but the record also lacked documentation of monitoring for effectiveness and side effects. In interviews, the physician stated an expectation that staff continuously monitor residents’ behavior and attempt nonpharmacological interventions before starting psychotropic drugs. An RN reported there was no system in place for documenting residents’ behaviors, and the DON stated she expected behavior monitoring for psychotropic effectiveness and side effects and orders for nonpharmacological interventions prior to drug therapy, but could not show evidence that such monitoring occurred for the cited residents.

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Resources

Below are regulatory guidelines relevant to this citation:

See other F0605 citations
PRN Antipsychotic Order Not Limited or Reassessed
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

PRN Antipsychotic Order Not Limited or Reassessed: A resident with advanced dementia, Alzheimer’s disease, agitation, and hospice services received PRN haloperidol for agitation and delirium under an open-ended order rather than a 14-day limit. Physician documentation continued the medication but did not show an evaluation of its ongoing need or an adequate rationale for renewal, and nursing notes did not document non-pharmacological interventions before one PRN dose was given.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Lack of Behavior Monitoring for Antipsychotic Use
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with depression and delusional disorders was prescribed Olanzapine for delusions, but the MAR and care plan showed no targeted behavior monitoring or other behavioral documentation to support the medication’s use or effectiveness. The SS Director and DNS both confirmed the resident was not on behavior monitoring, despite the facility stating residents on antipsychotics were placed on it.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Antipsychotic Use Lacked Documented Diagnosis Support
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with severe dementia and behavioral symptoms received Seroquel with multiple dose increases, but the orders did not include a documented diagnosis to justify use or escalation. The chart showed dementia, agitation, and later psychosis documentation, while staff described the resident as generally directable and pleasant with more evening behaviors. The resident also had falls during the stay, including one that led to ER transfer.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
PRN Lorazepam Lacked Required Stop Date and Rationale
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with anxiety, restlessness, agitation, and moderately impaired cognition received PRN lorazepam for anxiety, but the order had no stop date and the EHR lacked a documented duration with physician rationale for continued use. The psychotropic care plan did not address the PRN lorazepam, and an RN verified the facility had not obtained the required 14-day stop date or documentation for ongoing use.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Incomplete Psychotropic Behavior Monitoring and Orthostatic BP Documentation
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

Incomplete Psychotropic Monitoring Documentation: The facility did not complete or accurately document monthly behavior summaries for a resident receiving Ativan, quetiapine, risperidone, and sertraline, and another resident’s behavior summary for lurasidone HCl and fluoxetine HCl was inaccurate compared with the MAR. The same resident also lacked complete orthostatic BP monitoring documentation, as the required sitting readings were not recorded within the appropriate time frame. The SSD and DON verified the missing and incorrect documentation.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Psychotropic Medication Consent and GDR Documentation Failure
E
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with CVA and dementia, and severe cognitive impairment, received trazodone for depression without a completed medication consent form before the medication was administered. The record also showed a pharmacist-recommended GDR was declined with documentation that family routinely declines GDRs, but the rationale did not state that a further dose reduction would likely impair function or cause psychiatric instability, as required.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Citation search

Search every citation & Plan of Correction

Go to search
Citation watch

Track new serious citations across Rhode Island

Get a heads-up on the newest immediate-jeopardy (J–L) citations in Rhode Island — where surveyors are focused right now.

Free · about one email a month

Trusted data from CMS and state health departments

Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.

In your survey window? See what surveyors are citing.

The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.

Get the Survey-Prep Report
An unhandled error has occurred. Reload 🗙

Connection lost — reconnecting… We couldn't reconnect automatically. Please reload the page to continue.